Spinocerebellar ataxia type 3/Machado-Joseph disease manifested as spastic paraplegia: A clinical and genetic study

Song,Yanmin; Liu,Yunhai; Zhang,Ning; Long,Lili

doi:10.3892/etm.2014.2136

Spinocerebellar ataxia type 3/Machado-Joseph disease manifested as spastic paraplegia: A clinical and genetic study

Authors:
- Yanmin Song
- Yunhai Liu
- Ning Zhang
- Lili Long
View Affiliations

Affiliations: Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China
Published online on: December 16, 2014 https://doi.org/10.3892/etm.2014.2136
Pages: 417-420

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to conduct a familial investigation and provide a genetic diagnosis to a family presenting with spastic paraplegia and clinically diagnosed with hereditary spastic paraplegia (HSP). Blood samples were obtained from the family, and mutations in the gene causing spinocerebellar ataxia type 3 (SCA3)/Machado‑Joseph disease (MJD), known as MJD1, were analyzed using the polymerase chain reaction, 8% denaturing polyacrylamide gel electrophoresis, and T‑vector ligation and sequencing. The trinucleotide repeat number of the mutant allele was 80, leading to a genetic diagnosis of SCA3/MJD. This suggests that patients with SCA3/MJD characteristically present with typical spastic paraplegia without evident manifestations of ataxia. For those families with HSP involving the nervous system and showing genetic anticipation, an MJD1 genetic diagnosis should be considered to assist in clinical diagnosis of HSP.

View Figures

View References

1	McMonagle P, Webb S and Hutchinson M: The prevalence of ‘pure’ autosomal dominant hereditary spastic paraparesis in the island of Ireland. J Neurol Neurosurg Psychiatry. 72:43–46. 2002. View Article : Google Scholar : PubMed/NCBI
2	Silva MC, Coutinho P, Pinheiro CD, et al: Hereditary ataxias and spastic paraplegias: methodological aspects of a prevalence study in Portugal. J Clin Epidemiol. 50:1377–1384. 1997. View Article : Google Scholar
3	Fink JK: Hereditary spastic paraplegia. Curr Neurol Neurosci Rep. 6:65–76. 2006. View Article : Google Scholar : PubMed/NCBI
4	Coutinho P, Ruano L, Loureiro JL, et al: Hereditary ataxia and spastic paraplegia in Portugal: a population-based prevalence study. JAMA Neurol. 70:746–755. 2013. View Article : Google Scholar : PubMed/NCBI
5	Paulson H: Machado-Joseph disease/spinocerebellar ataxia type 3. Handb Clin Neurol. 103:437–449. 2012. View Article : Google Scholar
6	Jiang H, Tang B, Xia K, et al: Spinocerebellar ataxia type 6 in Mainland China: molecular and clinical features in four families. J Neurol Sci. 236:25–29. 2005. View Article : Google Scholar : PubMed/NCBI
7	Harding AE: Classification of the hereditary ataxias and paraplegias. Lancet. 21:1151–1155. 1983. View Article : Google Scholar
8	Li CM, Zhang C, Lu XL, et al: Clinical features and zygosity diagnosis of hereditary spastic paraplegia in identical twins. Zhoghua Shenjing Yixue Zazhi. 5:1122–1124. 2006.(In Chinese).
9	Medical Research Council. Aids to the Examination of the Peripheral Nervous System. Memorandum no. 45 London: Her Majesty’s Stationery Office; 1976
10	Mo DH, Xu H, Zhou W, et al: Susceptibility gene for stroke or cerebral infarction in the Han population in Hunan Province of China. Neural Regen Res. 8:1519–1527. 2013.PubMed/NCBI
11	Han Y, Zheng H, Ding S, et al: The clinical features and genomic diagnosis of hereditary spinocerebellar ataxia type 1. Cuzhong Yu Shenjing Jibing. 5:520–522. 2006.(In Chinese).
12	Gallassi R, Morreale A, Montagna P, et al: Fatal familial insomnia: behavioral and cognitive feaures. Neurology. 46:935–939. 1996. View Article : Google Scholar : PubMed/NCBI
13	Kong Q, Surewicz WK, Petersen RB, et al: Inherited prion diseases. Prion Biology and Diseases. Prusiner SB: 2nd edition. Cold Spring Harbor Laboratory Press; New York, NY: pp. 673–775. 2004
14	Sakai T and Kawakami H: Machado-Joseph disease: A proposal of spastic paraplegic subtype. Neurology. 46:846–847. 1996.PubMed/NCBI
15	Yun JY, Lee WW, Kim HJ, et al: Relative contribution of SCA2, SCA3 and SCA17 in Korean patients with parkinsonism and ataxia. Parkinsonism Relat Disord. 17:338–342. 2011. View Article : Google Scholar : PubMed/NCBI
16	Bettencourt C, Santos C, Coutinho P, et al: Parkinsonian phenotype in Machado-Joseph disease (MJD/SCA3): a two-case report. BMC Neurol. 11:1312011. View Article : Google Scholar : PubMed/NCBI
17	Maruyama H, Izumi Y, Morino H, et al: Difference in disease-free survival curve and regional distribution according to subtype of spinocerebellar ataxia: a study of 1,286 Japanese patients. Am J Med Genet. 114:578–583. 2002. View Article : Google Scholar : PubMed/NCBI
18	Maciel P, Gaspar C, DeStefano AL, et al: Correlation between CAG repeat length and clinical features in Machado-Joseph disease. Am J Hum Genet. 57:54–61. 1995.PubMed/NCBI